BioPorto
1.13 DKK
+4.63 %
Less than 1K followers
BIOPOR
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioPorto
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (DKK) | 2.33 | 3.89 | 2.38 | 2.23 | 2.09 | 1.55 | 1.02 |
| Shares | 220.3 | 181.9 | 278.4 | 348.0 | 379.7 | 429.7 | 495.1 |
| Market cap | 512.6 | 706.8 | 661.4 | 774.8 | 793.5 | 666.0 | 505.0 |
| Enterprise value | 496.0 | 606.8 | 629.3 | 700.5 | 734.4 | 617.5 | - |
| EV/S | 18.6 | 26.2 | 26.0 | 24.2 | 23.7 | 17.0 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 20.24 | 7.00 | 14.39 | 11.03 | 13.19 | 9.83 | 8.01 |
| P/S | 19.3 | 30.5 | 27.3 | 26.7 | 25.6 | 18.4 | 12.5 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 59.3 % | 71.9 % | 56.6 % | 64.6 % | 67.0 % | 70.6 % | 67.6 % |
| Gearing ratio | 6.1 % | 7.9 % | 29.3 % | 10.6 % | 12.1 % | 16.5 % | 11.9 % |